Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 41,954 | N/A | N/A |
| Marketable Securities | 313,862 | N/A | N/A |
| TOTAL | $360,536 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 8,094 | N/A | N/A |
| Other Non-Current Assets | 24,438 | 0 | 0 |
| TOTAL | $32,532 | $N/A | $N/A |
| Total Assets | $393,068 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 6,991 | 0 | 0 |
| Accrued Expenses | 3,746 | N/A | N/A |
| TOTAL | $11,986 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 561,520 | 0 | 0 |
| TOTAL | $561,520 | $N/A | $N/A |
| Total Liabilities | $573,506 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 4 | N/A | N/A |
| Retained earnings | -189,482 | N/A | N/A |
| Other shareholders' equity | 325 | 0 | 0 |
| TOTAL | $-180,438 | $N/A | $N/A |
| Total Liabilities And Equity | $393,068 | $0 | $0 |